News

John Reites, THREAD’s Chief Product Officer, will discuss eDROs and the FocalView App in this interview.

Right-to-Try bill sent to White House for President’s signature after passage by Congress.

Artificial intelligence is a "new weapon" in healthcare research.

From 2019, to comply with requirements for greater transparency around clinical research as part of the EU Clinical Trials Regulation 536/2014, life sciences firms will be expected to prepare plain-language summaries for all Phase I through IV interventional trials, which can be understood by patients, the general public, and experts.

When less is more. Using three referral labs vs. one central lab.

With the rise in gene therapies entering clinical trials, it is important to address the operational challenges associated with these types of trials.

The biopharmaceutical industry continues to explore how mHealth can change clinical trials, as the discussion continued at Hanson Wade’s mHealth for Clinical Trials EU Summit in London.

Updated employee announcements, business news, awards, and recognition in the industry today.

On Europe Day, the agency itself is right now keener than ever to assess its worth and the value of its services to Europe and to Europeans.

In this interview, Munther Baara, Head of New Clinical Paradigms at Pfizer, will discuss his perspectives on how blockchain may impact clinical trials.

A discussion of the cost and time put into clinical trials.

There are several pharmacokinetic factors and peculiarities that should be considered carefully when designing and running first-in-human (FIH) studies for monoclonal antibodies.